AmoyDx HANDLE Breast Cancer NGS Panel

Research-use HANDLE NGS panel for SNVs and InDels in 5 actionable breast cancer genes: AKT1, ERBB2, ESR1, PIK3CA and PTEN. It accepts both FFPE breast cancer tissue and plasma cell-free DNA, with a limit of detection of 0.2% VAF from cfDNA validated with the Seraseq ESR1 reference series. Runs on Illumina NextSeq 500/550/550Dx and Salus Pro with a turnaround of 4 working days; 24 tests per kit.

Target genes

AKT1, ERBB2, ESR1, PIK3CA and PTEN

Limit of detection

0.2% VAF from cfDNA

Compatibility

Illumina NextSeq 500/550/550Dx and Salus Pro

Turnaround time

4 working days

Kit size

24 tests per kit